BIONET Therapeutics Corp. (TPEX:7808)
Taiwan · Delayed Price · Currency is TWD 47.30
+0.05 (0.11%)
At close: Apr 20, 2026
BIONET Therapeutics Market Cap
BIONET Therapeutics has a market cap or net worth of 3.31 billion as of April 20, 2026. Its market cap has decreased by -12.50% in one year.
Market Cap
3.31B
Enterprise Value
2.26B
Revenue
154.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
47.30
Market Cap Chart
Since December 12, 2024, BIONET Therapeutics's market cap has decreased from 3.82B to 3.31B, a decrease of -13.30%. That is a compound annual growth rate of -10.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 3.31B | -15.93% |
| Dec 31, 2025 | 3.93B | 20.99% |
| Dec 31, 2024 | 3.25B | -14.77% |
| Dec 12, 2024 | 3.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accordance Systems | 3.33B |
| Optivision Technology | 3.33B |
| Adda Corporation | 3.32B |
| UVAT Technology | 3.31B |
| Tera Autotech | 3.31B |
| Kuen Ling Machinery Refrigerating | 3.29B |
| Ultra Chip | 3.29B |
| Shine-On BioMedical | 3.29B |